Vistin Pharma ASA (VISTN)

Add to research

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Company performance
Add to research
View more

Current Price

as of Jun 19, 2025

$2.44

P/E Ratio

14.15

Market Cap

$108.24M

Description
Add to research
View more

Vistin Pharma ASA is a pharmaceutical company, which engages in the production of Metformin Active Pharmaceutical Ingredients (API). It offers Metformin HCI and Metformin DC. The company was founded on March 6, 2015 and is headquartered in Oslo, Norway.

Metrics
Add to research
View more

Overview

  • HQOslo, PS
  • SectorHealth Technology
  • IndustryPharmaceuticals: Major
  • TickerVISTN
  • Price$2.442804-0.38%

Trading Information

  • Market cap$108.24M
  • Float47.32%
  • Average Daily Volume (1m)14,650
  • Average Daily Volume (3m)54,195
  • EPS$1.73

Company

  • Revenue$440.66M
  • Rev growth (1yr)10.74%
  • Net income$21.70M
  • Gross margin22.03%
  • EBITDA margin26.27%
  • EBITDA$30.22M
  • EV$1.07B
  • EV/Revenue2.43
  • P/E14.15
  • P/S2.47
  • P/B3.28
  • Debt/Equity0.33
Documents
Add to research
View more